Lifecore Biomedical Inc (LFCR)
5.77
-0.22
(-3.67%)
USD |
NASDAQ |
May 16, 16:00
5.78
+0.01
(+0.17%)
Pre-Market: 20:00
Lifecore Biomedical Price to Book Value
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| May 30, 2023 | 6.911 |
| May 26, 2023 | 7.038 |
| May 25, 2023 | 7.401 |
| May 24, 2023 | 7.410 |
| May 23, 2023 | 7.135 |
| May 22, 2023 | 4.751 |
| May 19, 2023 | 4.999 |
| May 18, 2023 | 4.644 |
| May 17, 2023 | 4.414 |
| May 16, 2023 | 4.006 |
| May 15, 2023 | 3.794 |
| May 12, 2023 | 3.811 |
| May 11, 2023 | 3.873 |
| May 10, 2023 | 3.997 |
| May 09, 2023 | 3.900 |
| May 08, 2023 | 3.962 |
| May 05, 2023 | 3.900 |
| May 04, 2023 | 3.856 |
| May 03, 2023 | 3.900 |
| May 02, 2023 | 3.811 |
| May 01, 2023 | 3.758 |
| April 28, 2023 | 3.767 |
| April 27, 2023 | 3.856 |
| April 26, 2023 | 3.740 |
| April 25, 2023 | 3.882 |
| Date | Value |
|---|---|
| April 24, 2023 | 3.864 |
| April 21, 2023 | 3.873 |
| April 20, 2023 | 3.483 |
| April 19, 2023 | 3.457 |
| April 18, 2023 | 3.404 |
| April 17, 2023 | 3.492 |
| April 14, 2023 | 3.395 |
| April 13, 2023 | 3.528 |
| April 12, 2023 | 3.350 |
| April 11, 2023 | 3.386 |
| April 10, 2023 | 3.315 |
| April 06, 2023 | 3.395 |
| April 05, 2023 | 3.288 |
| April 04, 2023 | 3.102 |
| April 03, 2023 | 3.253 |
| March 31, 2023 | 3.346 |
| March 30, 2023 | 3.359 |
| March 29, 2023 | 2.987 |
| March 28, 2023 | 2.943 |
| March 27, 2023 | 2.845 |
| March 24, 2023 | 2.765 |
| March 23, 2023 | 2.694 |
| March 22, 2023 | 2.885 |
| March 21, 2023 | 2.881 |
| March 20, 2023 | 2.748 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
0.9061
Minimum
Mar 25 2020
7.410
Maximum
May 24 2023
1.912
Average
1.571
Median
Price to Book Value Benchmarks
| Aquestive Therapeutics Inc | -- |
| SELLAS Life Sciences Group Inc | 8.767 |
| ADMA Biologics Inc | 13.66 |
| Relmada Therapeutics Inc | 1.462 |
| Jaguar Health Inc | 6.863 |
Price to Book Value Related Metrics
| Price | 5.77 |
| Market Cap | 176.26M |